-
Trump signs legislation to tackle opiate addiction
pharmaphorum
December 20, 2018
President Donald Trump has signed new legislation into law that he hopes will “end the scourge” of addiction to opiates in the US.
-
Trump administration block NIH researchers from using foetal tissue, disrupting research to cure HIV
pharmafile
December 11, 2018
The Trump Administration has halted the acquisition of new human foetal tissue for use in experiments conducted by NIH researchers, thus disrupting research into a cure for HIV.
-
Trump Medicare Plan Targets Drugs From AstraZeneca to Roche
firstwordpharma
November 28, 2018
A proposal from the US Centers for Medicare and Medicaid Services (CMS) could have negative consequences for a wide range of drugmakers, Bloomberg reported Tuesday.
-
Pfizer to hike prices of 41 drugs despite Trump criticism
pharmaphorum
November 27, 2018
Pfizer plans to raise the prices of 41 prescription drugs in January, despite falling foul of President Trump, who criticised the company’s stance on costs earlier this summer.
-
New US trade policy may limit foreign investment into biotechs
pharmafile
November 20, 2018
The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and testing of critical technologies
-
Trump administration, Senate move forward on pricing transparency proposals
fiercepharma
August 27, 2018
Months after President Donald Trump rolled out his administration’s drug pricing “blueprint,” wheels are in motion in Washington, D.C., as legislators and the federal government work to implement proposals pushing more transparency.
-
AbbVie's Trump tax rate cut—biggest in pharma—yields another $100M donation
fiercepharma
August 23, 2018
One of the many Ronald McDonald House Charities' families who stand to benefit from AbbVie's $100 million donation. (RMHC)
-
In defiance of Trump’s budget, Senate poised to boost NIH funding—again
fiercebiotech
August 22, 2018
Ignoring President Donald Trump’s proposed budget, the Senate is setting up to approve a $2 billion boost in funding for the National Institutes of Health. The increase is part of the Senate’s “minibus” for fiscal 2019 that deals with more than $850 billi
-
Trump urges Justice Department to target opioid makers with a ‘major lawsuit’
fiercepharma
August 20, 2018
Months ago, the Department of Justice backed the hundreds of lawsuits that accuse drugmakers and distributors of their alleged contribution to the nation’s opioid epidemic. Now, President Donald Trump is asking Attorney General Jeff Sessions to take anoth
-
Pfizer CEO psychs up investors for a rebate-free world under Trump
fiercepharma
August 02, 2018
What would a world with no drug rebates look like? Pfizer’s Ian Read is already imagining it.